Cargando…

Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia

A deficiency in glucose-6-phosphatase-α (G6Pase-α) in glycogen storage disease type Ia (GSD-Ia) leads to impaired glucose homeostasis and metabolic manifestations including hepatomegaly caused by increased glycogen and neutral fat accumulation. A recent report showed that G6Pase-α deficiency causes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cho, Jun-Ho, Kim, Goo-Young, Pan, Chi-Jiunn, Anduaga, Javier, Choi, Eui-Ju, Mansfield, Brian C., Chou, Janice Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469511/ https://www.ncbi.nlm.nih.gov/pubmed/28558013 http://dx.doi.org/10.1371/journal.pgen.1006819

Ejemplares similares

Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia
por: Lee, Young Mok, et al.
Publicado: (2015)

Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa)
por: Farah, Benjamin L., et al.
Publicado: (2017)

Geneotype and phenotype in 20 patients with glycogen storage disease type Ia
por: Liang, Cuili, et al.
Publicado: (2013)

Estimation of Health Utility Scores for Glycogen Storage Disease Type Ia
por: Kruger, Eliza, et al.
Publicado: (2023)

Glycogen Storage Disease Type Ia in Canines: A Model for Human Metabolic and Genetic Liver Disease
por: Specht, Andrew, et al.
Publicado: (2011)

Impaired Very‐Low‐Density Lipoprotein catabolism links hypoglycemia to hypertriglyceridemia in Glycogen Storage Disease type Ia
por: Hoogerland, Joanne A., et al.
Publicado: (2021)

A patient with glycogen storage disease type IA combined with hepatic adenoma: A case report
por: Yin, Maohui, et al.
Publicado: (2022)

Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia
por: den Hollander, N. C., et al.
Publicado: (2007)

Continuous glucose monitoring in the treatment of obesity in patients with glycogen storage disease type Ia
por: Korljan Jelaska, Betty, et al.
Publicado: (2013)

Glycogen storage disease type Ia: Adult presentation with microcytic anemia and liver adenomas
por: Moest, Wouter, et al.
Publicado: (2018)

Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs
por: Derks, Terry G. J., et al.
Publicado: (2021)

Diabetes mellitus in a patient with glycogen storage disease type Ia: a case report
por: Cohn, Aviva, et al.
Publicado: (2017)

Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia
por: Kang, Hye-Ri, et al.
Publicado: (2019)

A Novel Mutation in a Newborn Baby Leading to Glycogen Storage Disease Type Ia
por: Dorum, S, et al.
Publicado: (2018)

Papillary renal cell carcinoma in two young adults with glycogen storage disease type Ia
por: Perry, Ariane, et al.
Publicado: (2020)

Mitochondrial reprogramming in peripheral blood mononuclear cells of patients with glycogen storage disease type Ia
por: Rossi, Alessandro, et al.
Publicado: (2023)

A patient with glycogen storage disease type Ia combined with chronic hepatitis B infection: a case report
por: Wang, Wenying, et al.
Publicado: (2019)

Exosomal MicroRNAs as Potential Biomarkers of Hepatic Injury and Kidney Disease in Glycogen Storage Disease Type Ia Patients
por: Resaz, Roberta, et al.
Publicado: (2021)

Very early-onset inflammatory bowel disease: Novel description in glycogen storage disease type Ia
por: Hannah, William B., et al.
Publicado: (2022)

Case Report: Glycogen Storage Disease Type Ia in a Chinese Child Treated With Growth Hormone
por: Wu, Shimin, et al.
Publicado: (2022)

Double filtration plasmapheresis for pregnancy with hyperlipidemia in glycogen storage disease type Ia: A case report
por: Wang, Jie, et al.
Publicado: (2022)

Successful Treatment of Refractory Anemia in a Patient With Glycogen Storage Disease Type Ia Undergoing Hemodialysis
por: Sato, Hirotaka, et al.
Publicado: (2022)

Development of hepatocellular adenomas in a patient with glycogen storage disease Ia treated with growth hormone therapy
por: Jackson, David G., et al.
Publicado: (2023)

Bedtime extended release cornstarch improves biochemical profile and sleep quality for patients with glycogen storage disease type Ia
por: Hsu, Rai‐Hseng, et al.
Publicado: (2023)

SIRT1 is downregulated by autophagy in senescence and aging
por: Xu, Caiyue, et al.
Publicado: (2020)

A case report of acute pancreatitis with glycogen storage disease type IA in an adult patient and review of the literature
por: Ai, Jiaoyu, et al.
Publicado: (2020)

A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets
por: Rossi, Alessandro, et al.
Publicado: (2022)

Glycogen storage disease type Ia misdiagnosed as multiple acyl-coenzyme A dehydrogenase deficiency by mass spectrometry
por: Du, Juan, et al.
Publicado: (2022)

From Puppies to adults: In vivo editing of hepatocytes in a canine model of glycogen storage disease type Ia
por: Chandler, Randy J.
Publicado: (2023)

Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation
por: Melis, Daniela, et al.
Publicado: (2015)

Pituitary hypoplasia and growth hormone deficiency in a woman with glycogen storage disease type Ia: a case report
por: Dagdelen, Selcuk, et al.
Publicado: (2008)

Three novel mutations of the G6PC gene identified in Chinese patients with glycogen storage disease type Ia
por: Zheng, Bi-Xia, et al.
Publicado: (2014)

Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control
por: Peeks, Fabian, et al.
Publicado: (2017)

High childhood serum triglyceride concentrations associate with hepatocellular adenoma development in patients with glycogen storage disease type Ia
por: Haring, Martijn P.D., et al.
Publicado: (2022)

Yap signalling regulates ductular reactions in mice with CRISPR/Cas9-induced glycogen storage disease type Ia
por: Xie, Yixia, et al.
Publicado: (2022)

The rs2229611 (G6PC:c.*23 T>C) is associated with glycogen storage disease type Ia in Brazilian patients
por: Pinheiro, Franciele Cabral, et al.
Publicado: (2020)

Recurrent pancreatitis and sepsis in glycogen storage disease type Ia caused by complex heterozygous mutations in 2 sisters: Case report
por: Liu, Qin, et al.
Publicado: (2022)

Normalization of hepatic ChREBP activity does not protect against liver disease progression in a mouse model for Glycogen Storage Disease type Ia
por: Rutten, Martijn G. S., et al.
Publicado: (2023)

Crosstalk between Glycogen-Selective Autophagy, Autophagy and Apoptosis as a Road towards Modifier Gene Discovery and New Therapeutic Strategies for Glycogen Storage Diseases
por: Andjelkovic, Marina, et al.
Publicado: (2022)

Gastric cancer following a liver transplantation for glycogen storage disease type Ia (von Gierke disease): A case report
por: XIAO, HUA, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_feusss6cv9btqmak0ei8b43149